Development and application of an RT‒PCR assay for the identification of the delta and omicron variants of SARS-COV-2.

Autor: Shipulin GA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Savochkina Y; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Shuryaeva AK; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Glushchenko EE; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Luparev AR; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Polyakova VA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Danilov DI; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Davydova EE; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Vinogradov KS; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Stetsenko IF; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Aiginin AA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Matsvay AD; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Kolbutova KB; Chief Federal State Budgetary Healthcare Institution 'Centre of Hygiene and Epidemiology' of the Federal Medical Biological Agency, Moscow, Russia., Bogdan SA; Chief Federal State Budgetary Healthcare Institution 'Centre of Hygiene and Epidemiology' of the Federal Medical Biological Agency, Moscow, Russia., Vashukova MA; Clinical Infectious Diseases Hospital Named After S.P. Botkin, St. Petersburg, Russia., Yudin SM; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia.

Publikováno v: Heliyon [Heliyon] 2023 Jun; Vol. 9 (6), pp. e16917. Date of Electronic Publication: 2023 Jun 01.

The evaluation of five commercial bacteriophage cocktails against methicillin-resistant Staphylococcus aureus isolated from nasal swab samples.

Autor: Erol, Hilal Basak, Kaskatepe, Banu, Bakkaloglu, Zekiye, Suzuk Yildiz, Serap

Publikováno v: Archives of Microbiology; Nov2021, Vol. 203 Issue 9, p5735-5743, 9p

The development of medical education in Eastern Europe during the 20th century and the emergence of ‘English parallel’ courses.

Autor: Mayberry, JF

Publikováno v: Scottish Medical Journal; Feb2013, Vol. 58 Issue 1, p46-52, 7p

L'impero sovietico : (1917-1990)

Autor: Giovanni Codevilla

Il colpo di Stato del 1917 soffoca i fermenti di rinnovamento che dalla fine del secolo XIX si sviluppano nella società civile e nella Chiesa e che trovano espressione nella legge sulla tolleranza religiosa del 1905 e nella convocazione, dopo anni d